孤立性肺结节患者中风险相关的18F-FDG PET/CT与新的诊断策略:意大利多中心试验
这项回顾性多中心研究分析了502例按恶性风险分层的孤立性肺结节患者的18F-FDG PET/CT,比较全身PET/CT与胸部节段性PET/CT。36%为恶性、35%良性、29%性质未定;13%有胸部摄取、3%有胸外摄取;所有胸外转移者均有胸部淋巴结受累且结节处摄取最高(阴性预测值100%)。节段性PET/CT较全身可节省约2/3的18F-FDG剂量、辐射暴露或扫描时间,且不影响临床影响。
要点
- 孤立性肺结节患者中36%为恶性、35%良性、29%性质未定。
- 13%患者检出提示胸部病灶的18F-FDG摄取,3%检出提示胸外病灶的摄取。
- 所有胸外转移者均有胸部淋巴结受累且结节处摄取最高,阴性预测值100%。
核心结论
- 恶性肿瘤验前概率可指导孤立性肺结节患者的18F-FDG PET/CT诊断策略。
- 低-中等验前概率者可提前计划行节段性PET/CT,而高风险且伴胸部淋巴结受累者需行全身PET/CT。
研究设计与样本
- 回顾性多中心研究,分析502例按恶性肿瘤验前风险分层的患者的18F-FDG PET/CT。
- 将全身PET/CT的胸部部分视为节段性PET/CT,与全身PET/CT比较,并以组织病理学或随访数据为参考。
主要发现
- 研究人群中36%为恶性、35%为良性、29%为性质未定的孤立性肺结节。
- 13%的患者检出提示胸部病灶的18F-FDG摄取,3%检出提示胸外病灶的摄取。
- 所有胸外转移患者(n=13)均有胸部淋巴结受累且结节处18F-FDG摄取最高,阴性预测值100%。
- 与全身PET/CT相比,节段性PET/CT可节省约2/3的18F-FDG剂量、辐射暴露或扫描时间,且不影响PET/CT的临床影响。
临床怎么用
- 作者认为,恶性肿瘤验前概率可指导孤立性肺结节患者的18F-FDG PET/CT诊断策略。
- 作者认为,低-中等验前概率者可提前计划行节段性PET/CT。
- 作者认为,高风险且伴胸部淋巴结受累者需行全身PET/CT。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diagnosis of solitary pulmonary nodule (SPN) is an important public health issue and 18F-FDG PET/CT has proven to be more effective than CT alone. Pre-test risk stratification and clinical presentation of SPN could affect the diagnostic strategy. A relevant issue is whether thoracic segmental (s)-PET/CT could be implemented in patients with SPN. This retrospective multicenter study compared the results of FDG whole-body (wb)-PET/CT to those of s-PET/CT. METHODS: 18F-FDG PET/CT of 502 patients, stratified for pre-test cancer risk, were retrospectively analyzed. The thoracic part of wb-PET/CT, considered s-PET/CT, was compared to wb-PET/CT. Clinical and PET/CT variables were investigated for SPN characterization as well as for identification of patients in whom s-PET/CT could be performed. Histopathology or follow-up data were used as a reference. RESULTS: In the study population, 36% had malignant, 35% benign, and 29% indeterminate SPN. 18F-FDG uptake indicative of thoracic and extra-thoracic lesions was detectable in 13% and 3% of the patients. All patients with extra-thoracic metastases (n = 13) had thoracic lymph node involvement and highest 18F-FDG uptake at level of SPN (negative predictive value 100%). Compared to wb-PET/CT, s-PET/CT could save about 2/3 of 18F-FDG dose, radiation exposure or scan-time, without affecting the clinical impact of PET/CT. CONCLUSION: Pre-test probability of malignancy can guide the diagnostic strategy of 18FDG-PET/CT in patients with SPN. In subjects with low-intermediate pretest probability s-PET/CT imaging might be planned in advance, while in those at high risk and with thoracic lymph node involvement a wb-PET/CT is necessary.
引用
- Spadafora M, Pace L, Evangelista L, et al. Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial. Eur J Nucl Med Mol Imaging. 2018. PMID: 29730697. doi:10.1007/s00259-018-4043-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。